United States Biotechnology & Medical Research

Tevogen Bio Holdings Inc (TVGN)

Track

Tevogen Bio Holdings Inc. has seen no insider trading activity within the last three months. The most recent transactions occurred in March 2026, involving sales by Neal Flomenberg. Prior filings include proposed divestments by Kirti Desai earlier that year. These historical patterns reflect periodic equity liquidations by company personnel.
Ticker: TVGN Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tevogen Bio Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
Flomenberg Neal See Remarks Officer
Transaction date
Sale
Price
460.13
Quantity 35,674 -22.5%
Value US$2,387,945
3.4
Flomenberg Neal See Remarks Officer
Transaction date
Sale
Price
179.72
Quantity 4,638 +18.0%
Value US$1,612,120
3.4
Flomenberg Neal See Remarks Officer
Transaction date
Sale
Price
98.22
Quantity 71,871 -16.2%
Value US$295,735
0.5
Desai Kirti Officer Officer
Transaction date
Proposed sale
Price
0.31
Quantity 330,000
Value US$103,224
0.5
Desai Kirti Officer Officer
Transaction date
Proposed sale
Price
0.40
Quantity 15,500
Value US$6,149
2.8
Saadi Ryan H. Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
1.10
Quantity 1,438,206
Value US$1,582,027
2.8
Saadi Ryan H. Chief Executive Officer Executive Director Large shareholder
Transaction date
Sale
Price
1.23
Quantity 1,438,206 -1.2%
Value US$1,768,993
3.4
Flomenberg Neal See Remarks Officer
Transaction date
Sale
Price
1.09
Quantity 232,968 -6.1%
Value US$253,935
3.4
Flomenberg Neal See Remarks Officer
Transaction date
Sale
Price
1.05
Quantity 70,252 -1.8%
Value US$73,765
3.4
Flomenberg Neal See Remarks Officer
Transaction date
Sale
Price
1.09
Quantity 70,384 -1.8%
Value US$76,719
3.4
Flomenberg Neal See Remarks Officer
Transaction date
Sale
Price
1.14
Quantity 71,273 -1.8%
Value US$81,251
3.4
Flomenberg Neal See Remarks Officer
Transaction date
Sale
Price
1.10
Quantity 88,519 -2.1%
Value US$97,371
3.4
Flomenberg Neal See Remarks Officer
Transaction date
Sale
Price
1.21
Quantity 110,659 -2.6%
Value US$133,897
3.4
Flomenberg Neal See Remarks Officer
Transaction date
Sale
Price
1.28
Quantity 14,639 -0.3%
Value US$18,738
3.4
Flomenberg Neal See Remarks Officer
Transaction date
Sale
Price
1.62
Quantity 1,078,600 -20.2%
Value US$1,747,332
0.5
Desai Kirti Chief Financial Officer Officer
Transaction date
Purchase
Price
0.82
Quantity 3,000 +0.0%
Value US$2,460
2.8
Saadi Ryan H. Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.77
Quantity 2,607 +0.0%
Value US$2,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-17 2026-03-13 S Sale
3.4
Flomenberg Neal

See Remarks

Officer
35,674 -22.5%
460.13
US$2,387,945 		35,674 -22.5% 460.13 US$2,387,945
2026-03-17 2026-03-11 S Sale
3.4
Flomenberg Neal

See Remarks

Officer
4,638 +18.0%
179.72
US$1,612,120 		4,638 +18.0% 179.72 US$1,612,120
2026-03-17 2026-03-10 S Sale
3.4
Flomenberg Neal

See Remarks

Officer
71,871 -16.2%
98.22
US$295,735 		71,871 -16.2% 98.22 US$295,735
2026-02-06 2026-02-06 PrS Proposed sale
0.5
Desai Kirti

Officer

Officer
330,000
0.31
US$103,224 		330,000 0.31 US$103,224
2025-12-30 2025-12-30 PrS Proposed sale
0.5
Desai Kirti

Officer

Officer
15,500
0.40
US$6,149 		15,500 0.40 US$6,149
2025-06-09 2025-06-09 PrS Proposed sale
2.8
Saadi Ryan H.

Officer; Director; 10% Stockholder

Executive Director Large shareholder
1,438,206
1.10
US$1,582,027 		1,438,206 1.10 US$1,582,027
2025-06-09 2025-06-09 S Sale
2.8
Saadi Ryan H.

Chief Executive Officer

Executive Director Large shareholder
1,438,206 -1.2%
1.23
US$1,768,993 		1,438,206 -1.2% 1.23 US$1,768,993
2025-03-14 2025-03-12 S Sale
3.4
Flomenberg Neal

See Remarks

Officer
232,968 -6.1%
1.09
US$253,935 		232,968 -6.1% 1.09 US$253,935
2025-03-11 2025-03-11 S Sale
3.4
Flomenberg Neal

See Remarks

Officer
70,252 -1.8%
1.05
US$73,765 		70,252 -1.8% 1.05 US$73,765
2025-03-11 2025-03-10 S Sale
3.4
Flomenberg Neal

See Remarks

Officer
70,384 -1.8%
1.09
US$76,719 		70,384 -1.8% 1.09 US$76,719
2025-03-11 2025-03-07 S Sale
3.4
Flomenberg Neal

See Remarks

Officer
71,273 -1.8%
1.14
US$81,251 		71,273 -1.8% 1.14 US$81,251
2025-03-06 2025-03-06 S Sale
3.4
Flomenberg Neal

See Remarks

Officer
88,519 -2.1%
1.10
US$97,371 		88,519 -2.1% 1.10 US$97,371
2025-03-06 2025-03-05 S Sale
3.4
Flomenberg Neal

See Remarks

Officer
110,659 -2.6%
1.21
US$133,897 		110,659 -2.6% 1.21 US$133,897
2025-03-06 2025-03-04 S Sale
3.4
Flomenberg Neal

See Remarks

Officer
14,639 -0.3%
1.28
US$18,738 		14,639 -0.3% 1.28 US$18,738
2024-10-18 2024-10-17 S Sale
3.4
Flomenberg Neal

See Remarks

Officer
1,078,600 -20.2%
1.62
US$1,747,332 		1,078,600 -20.2% 1.62 US$1,747,332
2024-06-13 2024-06-12 B Purchase
0.5
Desai Kirti

Chief Financial Officer

Officer
3,000 +0.0%
0.82
US$2,460 		3,000 +0.0% 0.82 US$2,460
2024-06-07 2024-06-05 B Purchase
2.8
Saadi Ryan H.

Chief Executive Officer

Executive Director Large shareholder
2,607 +0.0%
0.77
US$2,000 		2,607 +0.0% 0.77 US$2,000
2023-07-18 2023-07-17 S Sale
3.0
Corbin Capital Partners, L.P.
Large shareholder
1,716,800 -100.0%
10.68
US$18,335,424 		1,716,800 -100.0% 10.68 US$18,335,424
2023-07-18 2023-07-17 S Sale
3.0
Corbin Capital Partners, L.P.
Large shareholder
603,200 -100.0%
10.68
US$6,442,176 		603,200 -100.0% 10.68 US$6,442,176
2023-06-08 2023-06-07 S Sale
Semper Paratus Sponsor LLC
Large shareholder
8,988,889 -67.7%
1.00
US$8,988,889 		8,988,889 -67.7% 1.00 US$8,988,889
2021-11-08 2021-11-08 B Purchase
Semper Paratus Sponsor LLC
Large shareholder
1,300,000
0.00
US$0 		1,300,000 0.00 US$0
Explore more

More insider trading research around Tevogen Bio Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America